Howard W Robin Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

Howard W Robin is President & CEO of NEKTAR THERAPEUTICS. Currently has a direct ownership of 832,080 shares of NKTR, which is worth approximately $832,080. The most recent transaction as insider was on Feb 02, 2021, when has been sold 150,000 shares (Common Stock) at a price of $8.8 per share, resulting in proceeds of $1,320,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 832K
1.92% 3M change
7.54% 12M change
Total Value Held $832,080

HOWARD W ROBIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
BUY
Exercise of conversion of derivative security
$1,320,000 $8.8 p/Share
150,000 Added 19.77%
608,693 Common Stock
Dec 18 2020
BUY
Grant, award, or other acquisition
-
106,650 Added 18.86%
458,693 Common Stock
Nov 16 2020
SELL
Open market or private sale
$202,737 $16.93 p/Share
11,975 Reduced 3.29%
352,043 Common Stock
HWR

Howard W Robin

President & CEO
San Francisco, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR